Table 1.
Antimicrobial class | Antimicrobial agent | Range (μg/ml) | ECOFFa | CLSIb or NARMSc | |||
---|---|---|---|---|---|---|---|
E. coli | Salmonella spp. | S | I | R | |||
Aminoglycosides | Gentamicin | 0.25–16 | 2 | 2 | ≤ 4 | 8 | ≥16 |
Streptomycin | 2–64 | 16 | 16 | ≤ 32 | – | > 32 | |
β-lactam / β-lactam inhibitor combinations | Amoxicillin-clavulanate | 1–32 | –d | – | ≤ 8 | 16 | ≥32 |
Cephems | Cefoxitin | 0.5–32 | 8 | 8 | ≤ 8 | 16 | ≥32 |
Ceftiofur | 0.12–8 | 1 | 2 | ≤ 2 e | 4 | ≥8 | |
Ceftriaxone | 0.25–64 | 0.12 | – | ≤ 1 | 2 | ≥4 | |
Fluoroquinolones | Ciprofloxacin (E. coli) | 0.015–4 | 0.06 | 0.06 | ≤ 1 | 2 | ≥4 |
Ciprofloxacin (Salmonella spp.) | 0.015–4 | 0.06 | 0.06 | ≤ 0.06 | 0.12–0.5 | ≥1 | |
Folate pathway inhibitors | Trimethoprim-sulfamethoxazole | 0.12–4 | 1 | 1 | ≤ 2 | – | ≥4 |
Penicillins | Ampicillin | 1–32 | 8 | 8 | ≤ 8 | 16 | ≥32 |
Phenicols | Chloramphenicol | 2–32 | 16 | 16 | ≤ 8 | 16 | ≥32 |
Tetracyclines | Tetracycline | 4–32 | 8 | 8 | ≤ 4 | 8 | ≥16 |
EUCAST epidemiological cut-off values (μg/ml).
CLSI VET01S, or M100S breakpoints (μg/ml), S = sensitive; I = intermediate; R = resistant.
NARMS breakpoints (μg/ml) (in blue).
not defined.
E. coli only.